Register to receive a free US Market Report Suite for Orthopedic Trauma Devices 2017 report synopsis and brochure

According to a new series of reports on the U.S. orthopedic trauma device market by iData Research, one of the major drivers of this market is the consistent influx of newer technologies replacing traditional devices like plates and screws with higher cost of anatomical contouring hybrid locking titanium systems.

“The largest segment in the total trauma device market is the plate and screw market,” explains Dr. Kamran Zamanian, CEO of iData. “The relatively large size of this segment is due to the popularity of this fixation option manifested in a high volume of unit sold and complimented with relatively strong average selling prices (ASPs).”

The majority of total trauma market unit sales consist of devices used in the hospital setting and outpatient facilities, such as ambulatory surgery centers (ASCs). The fastest growing part of this market is the staple fixation segment. This segment is also expected to remain the fastest growing through 2023. The main reasons for the strong growth of this segment is the increasing adoption of nitinol based staples and its popularity due to the reduced operating times it allows when compared to screws.

The market is limited by purchasing entities and third-party insurers reducing budgets by ignoring the differences between the various type of plates and screws. In such circumstances, a single price is set for what the entity would be willing to pay for a certain construct, which discourages the use of the more expensive options available on the market.

In the case of conventional hip screws, the decline is due to the growing popularity of competing trochanteric hip nail systems. Although trochanteric hip nail systems are continuing to take share of this growing indication, there is a possibility of the conventional hip screw market regaining some popularity as the reimbursement environment becomes more restrictive, giving hospitals fewer options. As a result, their substantially lower ASPs would make them more attractive to cost-conscious purchasers.

Although the trauma market is maturing, there are still significant growth niches which could be explored. Recent acquisitions of key products by major trauma companies are expected to unlock significant growth over the next several years. DePuy Synthes leads the U.S. orthopedic trauma market by maintaining its majority share of the plate and screw market, as well holding a top position in most of the other segments.

Stryker continues to dominate the intramedullary hip screw market, as well as maintain a key position in several other major segments, securing it the second leading spot in the overall market. Additional competitors in the U.S. orthopedic trauma device market include Zimmer Biomet, Smith & Nephew, Bioventus, Wright Medical, Acumed, Orthofix, Arthrex, DJO Global, I.T.S, Integra LifeSciences, BioPro, ConMed, OsteoMed and Vilex among others.

For Further Information
More on the orthopedic trauma device market in the U.S. can be found in a series of reports published by iData Research entitled the US Market Report Suite for Orthopedic Trauma Devices 2017.